Knoll Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Knoll Capital Management's ALT Position: Q3 2026 in Review
Knoll Capital Management sold out of Altimmune (ALT) in Q3 2026, closing a stake of 160,000 shares — an estimated $486K sold.
Knoll Capital Management first reported a position in ALT in Q4 2020 and held it in 22 quarters. The position peaked at $8.09M in Q4 2024. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Knoll Capital Management reported no remaining Altimmune position as of Q3 2026 after selling out during the quarter.
- Knoll Capital Management sold 160,000 Altimmune shares in Q3 2026, an estimated $486K.
- Knoll Capital Management first reported a position in Altimmune in Q4 2020 and held it in 22 quarters.
- Knoll Capital Management's Altimmune position peaked at $8.09M in Q4 2024.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Knoll Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.